Citation: Jk. Jones et al., VALUE OF EPIDEMIOLOGIC STUDIES IN DETERMINING THE INCIDENCE OF ADVERSE EVENTS - THE NSAID STORY, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 7-7
Citation: Lj. Miwa et al., VALUE OF EPIDEMIOLOGIC STUDIES IN DETERMINING THE TRUE INCIDENCE OF ADVERSE EVENTS - THE NONSTEROIDAL ANTIINFLAMMATORY DRUG STORY, Archives of internal medicine, 157(18), 1997, pp. 2129-2136